The Tohoku Journal of Experimental Medicine
Online ISSN : 1349-3329
Print ISSN : 0040-8727
ISSN-L : 0040-8727
Mass Screening for Neuroblastoma in Miyagi Prefecture
MASAYUKI ITANOSEI MORITAHIROMI FUJIEYOSHIYUKI OHASHINAOKO MINEGISHIMASAYOSHI MINEGISHIYOSHIKO YAMAGUCHITETSUO SATOSHIGERU TSUCHIYATASUKE KONNOYUTAKA HAYASHIRYOJI OHIHIROYUKI SHIRAISHI
著者情報
ジャーナル フリー

1992 年 168 巻 2 号 p. 137-139

詳細
抄録
ITANO, M., MORITA, S., FUJIE, H., OHASHI, Y., MINEGISHI, N., MINEGISHI, M., YAMAGUCHI, Y., SATO, T., TSUCHIYA, S., KONNO, T., HAYASHI, Y., OHI, R. and SHIRAISHI, H. Mass Screening for Neuroblastoma in Miyagi Prefecture. Tohoku J. Exp. Med., 1992, 168 (2), 137-139 - In Japan, aiming at early and preclinical detection of neuroblastoma in infancy a mass screening program for the tumor has been implemented nationwide using urinary tests for catecholamine metabolites, vanillylmandelic acid (VMA) and homovanillic acid (HVA) (Sawada 1990; Sawada et al. 1991). In this report, the results obtained from the screening program in Miyagi Prefecture for the last 6 years are described. The detection rate of neuroblastoma by mass screening was 1:8, 377 among 125, 652 infants tested in Miyagi Prefecture. All but one patients survived after removal of the primary tumor and none or minimal chemotherapy. - neuroblastoma; mass screening; urine VMA; urine HVA
著者関連情報
© Tohoku University Medical Press
前の記事 次の記事
feedback
Top